J. Steven Kammerer

J. Steven Kammerer

Auto-generated profile, based on publicly available information

J. Steven Kammerer

Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in International Journal of Health Geographics
Verified
Journal Article
Open access
PDF file
JKJ Steve Kammerer
J Steve Kammerer
NSNong Shang
Nong Shang
SASandy P Althomsons
Sandy P Althomsons
MHMaryam B Haddad
Maryam B Haddad
JGJuliana Grant
Juliana Grant
TNThomas R Navin
Thomas R Navin
Early identification of outbreaks remains a key component in continuing to reduce the burden of infectious disease in the United States. Previous studies have applied statistical methods to detect unexpected cases of disease in space or time. The objectives of our study were to assess the ability and timeliness of three spatio-temporal methods to detect known outbreaks of tuberculosis.

1 February 2005 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
JKJ. Steve Kammerer
J. Steve Kammerer
SMScott J.N. McNabb
Scott J.N. McNabb
JBJose E. Becerra
Jose E. Becerra
LRLisa Rosenblum
Lisa Rosenblum
NSNong Shang
Nong Shang
TNThomas R. Navin
Thomas R. Navin


21 October 2016 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
OCon behalf of the Tuberculosis Epidemiologic Studies Consortium
on behalf of the Tuberculosis Epidemiologic Studies Consortium
LTLarry D. Teeter
Larry D. Teeter
PVPadmaja Vempaty
Padmaja Vempaty
DNDuc Nguyen
Duc Nguyen
JTJane Tapia
Jane Tapia
EGEdward A. Graviss
Edward A. Graviss
Tracking the dissemination of specific Mycobacterium tuberculosis (Mtb) strains using genotyped Mtb isolates from tuberculosis patients is a routine public health practice in the United States. The present study proposes a standardized cluster investigation method to identify epidemiologic-linked patients in Mtb genotype clusters. The study also attempts to determine the proportion of epidemiologic-linked patients the proposed method would identify beyond the outcome of the conventional contact investigation. The study population included Mtb culture positive patients from Georgia, Maryland, Massachusetts and Houston, Texas. Mtb isolates were genotyped by CDC’s National TB Genotyping Service (NTGS) from January 2006 to October 2010. Mtb cluster investigations (CLIs) were conducted for patients whose isolates matched exactly by spoligotyping and 12-locus MIRU-VNTR. CLIs were carried out in four sequential steps: (1) Public Health Worker (PHW) Interview, (2) Contact Investigation (CI) Evaluation, (3) Public Health Records Review, and (4) CLI TB Patient Interviews. Comparison between patients whose links were identified through the study’s CLI interviews (Step 4) and patients whose links were identified earlier in CLI (Steps 1–3) was conducted using logistic regression. Forty-four clusters were randomly selected from the four study sites (401 patients in total). Epidemiologic links were identified for 189/401 (47 %) study patients in a total of 201 linked patient-pairs. The numbers of linked patients identified in each CLI steps were: Step 1 - 105/401 (26.2 %), Step 2 - 15/388 (3.9 %), Step 3 - 41/281 (14.6 %), and Step 4 - 28/119 (30 %). Among the 189 linked patients, 28 (14.8 %) were not identified in previous CI. No epidemiologic links were identified in 13/44 (30 %) clusters. We validated a standardized and practical method to systematically identify epidemiologic links among patients in Mtb genotype clusters, which can be integrated into the TB control and prevention programs in public health settings. The CLI interview identified additional epidemiologic links that were not identified in previous CI. One-third of the clusters showed no epidemiologic links despite being extensively investigated, suggesting that some improvement in the interviewing methods is still needed.

17 August 2026 in Public Health Reports®
Verified
Journal Article
Closed access
CMClinton J. McDaniel
Clinton J. McDaniel
STSarah Talarico
Sarah Talarico
KRKala M. Raz
Kala M. Raz
SKSteve Kammerer
Steve Kammerer
SPShameer Poonja
Shameer Poonja
BSBenjamin J. Silk
Benjamin J. Silk
Objectives: Estimating the percentage of tuberculosis cases in a population attributable to recent transmission, compared with reactivation of past infections, is crucial for public health decision-making. This study evaluated a previously published plausible-source case (PSC) method for estimating recent transmission in Los Angeles County (LA County) against a reference standard based on epidemiologic and whole-genome sequencing data. Methods: We analyzed tuberculosis cases diagnosed in LA County from 2014 through 2018 using surveillance data. Cases were classified as consistent or inconsistent with recent transmission using the PSC method and a stepwise review of epidemiologic links and single nucleotide polymorphisms (Epi/SNP). We compared classifications from both methods and assessed discrepancies. Results: Of 2949 tuberculosis cases in LA County, 650 had epidemiologic and whole-genome sequencing data for evaluating recent transmission; 44 were excluded due to missing genotyping data, including 7 pediatric patients aged <15 years. The Epi/SNP review classified 195 (30%) cases as consistent with recent transmission, while the PSC method attributed 301 (46%) cases to recent transmission. The 2 methods agreed on 454 (70%) cases. Discrepancies arose from genetic diversity, geographic distance, nonmatching genotypes, and diagnosis timing. Performance varied by race and ethnicity, nativity, lineage, history of homelessness, and substance use. Conclusions: The PSC method accurately classified more than two-thirds of tuberculosis cases included in a cluster investigation in LA County. However, findings underscore the need to refine the PSC method by integrating whole-genome sequencing data, including nongenotyped cases in pediatric patients, and reevaluating the geographic and timing criteria to enhance completeness and inform public health interventions aimed at interrupting tuberculosis transmission.